EDUCATION HISTORY
FellowshipUniversity of Utah School of Medicine
Hematology/Oncology
Fellow, 2007
FellowshipUniversity of Iowa Hospitals and Clinics
Geriatrics
Fellow, 2004
ResidencyUniversity of Iowa Hospitals and Clinics
Internal Medicine
Resident, 2003
InternshipAdvocate Illinois Masonic Medical Center
Internal Medicine
Intern, 2001
Professional MedicalAll India Institute of Medical Sciences
Medicine
M.D., 2000
Certifications, Licensures
ABIM Board Certifications:
10/2008 Diplomate (Board Certification) in Hematology
11/2007 Diplomate (Board Certification) in Medical Oncology
12/ 2004-12/2014 Diplomate (Board Certification) in Geriatric Medicine
12/2003-12/2013 Diplomate (Board Certification) in Internal Medicine
Licensure:
2004-current Utah State Medical License
2001-2004 Iowa State Medical License
2000-2003 Illinois State Medical License
1998–current ECFMG – Physician (MD)
2004-2014 Controlled Substance (UT) – Physician (MD)
2004-2014 DEA Certificate (UT) – Physician (MD)
Other Training & Certifications:
2015 Selected Participant, Inaugural Integrated Translational Science Center (ITSC) Workshop (Cold Spring Harbor Laboratory and SWOG, funded by the Hope Foundation), Branbury Campus, Cold Spring Harbor Labs, June 18 – June 20, 2015, Long Island, NY.
2009 South West Oncology Group (SWOG) Young Investigator Training Course
2007 American Association of Cancer Research (AACR) and NCI sponsored “Molecular Biology in Clinical Oncology workshop”, Given Institute of the University of Colorado, Aspen, CO, July, 2007.
1999 Education Commission for Foreign Medical Graduates (ECFMG) Certification, Permanent validation, 11/1999
Dr Agarwal is a member of several professional societies, including the American Society of Clinical Oncology (ASCO), the American Association of Cancer Research, and the Southwest Oncology Group, and the Huntsman Cancer Institute.
Dr. Neeraj Agarwal is a Professor of medicine, and a Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute (HCI), University of Utah. He also directs the Genitourinary Oncology (GU) Program, and the Center of Investigational Therapeutics (CIT) at the HCI.
Dr. Agarwal is an internationally recognized physician scientist in the field of genitourinary cancers. He is the overall study chair of multiple Phase I/II and Phase III trials, and serves as a steering committee member of numerous other trials. He has received SWOG Young Investigator Award, the William D. Odell Young Investigator Award, and a National Cancer Institute Cancer Clinical Investigator Team Leadership Award. After receiving his medical training at the All India Institute of Medical Sciences in New Delhi, he completed a residency in internal medicine and a fellowship in geriatric medicine at the University of Iowa, followed by a hematology-oncology fellowship at HCI.
Dr. Agarwal has authored more than 350 peer-reviewed articles and book chapters. He serves as a panel member for the NCCN guideline committees for bladder and kidney cancers. He is an advisor to the Oncology Drug Advisory Committee and the United States Food and Drug Administration, and leads early therapeutics in the SWOG genitourinary cancers committee. He holds numerous scientific communications leadership roles, including chief editor of the ASCO Daily News, specialty editor for ASCO’s cancer.net site, and editorial board member of several journals, including Journal of Clinical Oncology and European Urology. He also serves as a member of the ASCO Genitourinary Cancers Advisory Panel. Recently, Dr. Agarwal was appointed as the Senior Director for Clinical Research Innovation, directly reporting to the cancer center director at the Huntsman Cancer Institute.